The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,036 | 826,779 | SH | SOLE | 826,779 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 33,651 | 88,816 | SH | SOLE | 88,816 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 21,778 | 517,406 | SH | SOLE | 517,406 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 40,175 | 432,170 | SH | SOLE | 432,170 | 0 | 0 | ||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 17,594 | 1,048,516 | SH | SOLE | 1,048,516 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 552 | 73,149 | SH | SOLE | 73,149 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 7,006 | 148,216 | SH | SOLE | 148,216 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 8,955 | 1,408,050 | SH | SOLE | 1,408,050 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 46,186 | 1,445,566 | SH | SOLE | 1,445,566 | 0 | 0 | ||
| GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 4,309 | 783,445 | SH | SOLE | 783,445 | 0 | 0 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 24,901 | 667,417 | SH | SOLE | 667,417 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 42,243 | 556,043 | SH | SOLE | 556,043 | 0 | 0 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 53,823 | 978,596 | SH | SOLE | 978,596 | 0 | 0 | ||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,710 | 850,961 | SH | SOLE | 850,961 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 10,239 | 452,244 | SH | SOLE | 452,244 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 44,304 | 659,968 | SH | SOLE | 659,968 | 0 | 0 | ||
| OYSTER PT PHARMA INC | COM | 69242L106 | 5,773 | 1,333,330 | SH | SOLE | 1,333,330 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 44,064 | 801,314 | SH | SOLE | 801,314 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 16,857 | 876,156 | SH | SOLE | 876,156 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 8,350 | 1,964,709 | SH | SOLE | 1,964,709 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 38,425 | 163,066 | SH | SOLE | 163,066 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 15,117 | 1,306,569 | SH | SOLE | 1,306,569 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 6,482 | 1,304,300 | SH | SOLE | 1,304,300 | 0 | 0 | ||